Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges
Boxes of tablets produced by Teva Pharmaceutical Industries.Chris Ratcliffe | Bloomberg | Getty ImagesDrugmaker Teva Pharmaceuticals agreed to pay $225 million in criminal fines to resolve charges related to price fixing three medications, including a generic cholesterol drug that it has agreed to divest, the U.S. Department of Justice announced Monday.Glenmark Pharmaceuticals will pay $30 million… […]